Frank Mannino

593 total citations
14 papers, 366 citations indexed

About

Frank Mannino is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Frank Mannino has authored 14 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Frank Mannino's work include Statistical Methods in Clinical Trials (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Frank Mannino is often cited by papers focused on Statistical Methods in Clinical Trials (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Frank Mannino collaborates with scholars based in United States, United Kingdom and Spain. Frank Mannino's co-authors include Valerii V. Fedorov, Rongmei Zhang, Ohad Amit, Jeffrey D. Helterbrand, Jonathan Denne, William D. Bushnell, Hans-Ulrich Burger, A Stone, Sergei L. Kosakovsky Pond and Spencer V. Muse and has published in prestigious journals such as Blood, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Frank Mannino

14 papers receiving 348 citations

Peers

Countries citing papers authored by Frank Mannino

Since Specialization

Citations

This map shows the geographic impact of Frank Mannino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Mannino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Mannino more than expected).

Fields of papers citing papers by Frank Mannino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Mannino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Mannino. The network helps show where Frank Mannino may publish in the future.

Co-authorship network of co-authors of Frank Mannino

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Mannino. A scholar is included among the top collaborators of Frank Mannino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Mannino. Frank Mannino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax 2024 ·Antimicrobial Agents and Chemotherapy ·Jamese J. Hilliard, Charles Jakielaszek, Frank Mannino, Mohammad Sharif Hossain, Lian Qian, Cindy Fishman, Samandra T. Demons, Jeremy R. Hershfield, (unknown), Riccardo Russo, Lisa N. Henning, (unknown), Karen O’Dwyer	2
2	Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge 2023 ·Antimicrobial Agents and Chemotherapy ·Charles Jakielaszek, Jamese J. Hilliard, Frank Mannino, Mohammad Sharif Hossain, Lian Qian, Cindy Fishman, (unknown), Lisa N. Henning, (unknown), Samandra T. Demons, Jeremy R. Hershfield, Karen O’Dwyer	6
3	Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague 2022 ·Science Translational Medicine ·Charles Jakielaszek, Mohammad Sharif Hossain, Lian Qian, Cindy Fishman, Katherine L. Widdowson, Jamese J. Hilliard, Frank Mannino, Aparna Raychaudhuri, Élisabeth Carniel, Samandra T. Demons, Henry S. Heine, Jeremy R. Hershfield, Riccardo Russo, (unknown), (unknown), Karen O’Dwyer	9
4	Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1 2022 ·Antimicrobial Agents and Chemotherapy ·Margaret Gartland, Pedro Cahn, Edwin DeJesus, Ricardo Sobhie Diaz, Robert Grossberg, Michael D. Miller, Princy Kumar, Jean‐Michel Molina, (unknown), (unknown), (unknown), (unknown), Andrew Clark, (unknown), Mark Krystal, Frank Mannino, Amy Pierce, Peter Ackerman, Max Lataillade	10
5	Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration 2022 ·HIV Medicine ·Nneka Nwokolo, (unknown), (unknown), (unknown), Mindy Magee, Frank Mannino, Peter Ackerman, Andrew Clark, (unknown)	4
6	Equiprobable discrete models of site-specific substitution rates underestimate the extent of rate variability 2020 ·PLoS ONE ·Frank Mannino, Sadie R Wisotsky, Sergei L. Kosakovsky Pond, Spencer V. Muse	1
7	Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir 2020 ·The Journal of Clinical Pharmacology ·Mindy Magee, (unknown), Frank Mannino, Peter Ackerman, Cyril Llamoso, (unknown)	7
8	Phase 3, Placebo-Controlled, ASPIRE Study (TRC114968) of Eltrombopag (EPAG) Treatment of Thrombocytopenia (TCP) in Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Assessment of Clinical Benefit, Safety, and Tolerability 2015 ·Blood ·Moshe Mittelman, Uwe Platzbecker, Boris V. Afanasyev, Sebastian Grosicki, Raymond Wong, Αchilles Anagnostopoulos, Benjamin Brenner, Claudio Denzlinger, Giuseppe Rossi, Arnon Nagler, Ana Mas, Frank Mannino, Nicole L. Stone, Geoffrey Chan, Yasser Mostafa Kamel, Dominik Selleslag	2
9	Evaluation of Discordance Measures in Oncology Studies with Blinded Independent Central Review of Progression-Free Survival Using an Observational Error Model 2013 ·Journal of Biopharmaceutical Statistics ·Frank Mannino, Ohad Amit, Soumi Lahiri	3
10	Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study 2012 ·Blood ·Moshe Mittelman, Sarit Assouline, Evangelos Briasoulis, Arancha Alonso, (unknown), Peter O’Gorman, Hyeoung Joon Kim, Sung‐Soo Yoon, Andrey Zaritskey, Catherine Flynn, Yoo Hong Min, María Díez‐Campelo, Alexandr Myasnikov, Frank Mannino, Yasser Mostafa Kamel, Conrad A. Messam, Nicole L. Stone, Geoffrey Chan	8
11	Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis 2011 ·European Journal of Cancer ·Ohad Amit, Frank Mannino, A Stone, William D. Bushnell, Jonathan Denne, Jeffrey D. Helterbrand, Hans-Ulrich Burger	78
12	Consequences of dichotomization 2008 ·Pharmaceutical Statistics ·Valerii V. Fedorov, Frank Mannino, Rongmei Zhang	210
13	Evolutionary Model Selection with a Genetic Algorithm: A Case Study Using Stem RNA 2006 ·Molecular Biology and Evolution ·Sergei L. Kosakovsky Pond, Frank Mannino, Mike B. Gravenor, Spencer V. Muse, Simon D. W. Frost	18
14	Changes in monocyte phagocyting activity after multi-agent chemotherapy in non-small cell lung cancer. 2003 ·PubMed ·Salvatore Mariotta, (unknown), Alberto Rícci, Massimo Papale, (unknown), Bruno Sposato, Frank Mannino	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact